Title
A multicentric study regarding the use of hormone therapy during female mid-age (REDLINC VI)
Date Issued
01 January 2014
Access level
metadata only access
Resource Type
journal article
Author(s)
Blümel J.E.
Chedraui P.
Barón G.
Benítez Z.
Flores D.
Espinoza M.T.
Gomez G.
González E.
Hernández L.
Lima S.
Martino M.
Montaño A.
Monterrosa A.
Mostajo D.
Onatra W.
Robles C.
Saavedra J.
Sánchez H.
Tserotas K.
Vallejo M.S.
Vallejo C.
Collaborative Group for Research of the Climacteric in Latin America (Redlinc)
Publisher(s)
Informa Healthcare
Abstract
Background Menopausal hormone therapy (HT) has shown benefits for women; however, associated drawbacks (i.e. risks, costs, fears) have currently determined its low use. Objective To determine the prevalence of current HT use among mid-aged women and describe the characteristics of those who have never used, have abandoned or are currently using HT. In addition, reasons for not using HT were analyzed. Method This was a cross-sectional study that analyzed a total of 6731 otherwise healthy women (45-59 years old) of 15 cities in 11 Latin American countries. Participants were requested to fill out the Menopause Rating Scale (MRS) and a questionnaire containing sociodemographic data and items regarding the menopause and HT use. Results The prevalence of current HT use was 12.5%. Oral HT (43.7%) was the most frequently used type of HT, followed by transdermal types (17.7%). The main factors related to the current use of HT included: positive perceptions regarding HT (odds ratio (OR) 11.53, 95% confidence interval (CI) 9.41-14.13), being postmenopausal (OR 3.47, 95% CI 2.75-4.36) and having a better socioeconomic level. A total of 48.8% of surveyed women had used HT in the past, but abandoned it due to symptom improvement or being unconcerned; fear of cancer or any other secondary effects were also reported but in less than 10%. Among women who had never used HT, 28% reported the lack of medical prescription as the main reason, followed by the absence of symptoms (27.8%). Among those reporting lack of prescription as the main reason for not using HT, 30.6% currently had severe menopausal symptoms (total MRS score > 16); 19.5% of women were using alternative 'natural' therapies, with 35.1% of them displaying severe menopausal symptoms as compared to a 22.5% observed among current HT users. Conclusion The use of HT has not regained the rates observed a decade ago. Positive perceptions regarding HT were related to a higher use. Lack of medical prescription was the main reason for not using HT among non-users, many of whom were currently displaying severe menopausal symptoms. © 2014 International Menopause Society.
Start page
433
End page
441
Volume
17
Issue
4
Language
English
OCDE Knowledge area
Endocrinología, Metabolismo (incluyendo diabetes, hormonas) Salud pública, Salud ambiental
Scopus EID
2-s2.0-84904319121
PubMed ID
Source
Climacteric
ISSN of the container
13697137
Sources of information: Directorio de Producción Científica Scopus